Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • GSK vs EME✓SelectedUSD · EMEGSK vs EME performance historyLatest closeAs of-0.08%11/16
Stock and ETF performance explorer

GSK vs EME

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+9.8%
EME return
+3.1%
Excess return
+6.7%
Maximum drawdown
-22.4%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 1y.

Portfolio and benchmark returns by period
PeriodPortfolioEMEExcessAlpha
1D-0.1%-3.1%+3.1%-0.3%
7D-1.3%-2.2%+0.9%-1.5%
30D+2.7%-11.5%+14.2%+1.8%
3M+2.7%-23.6%+26.3%+1.3%
6M+3.3%-30.0%+33.3%+3.6%
YTD+6.5%+4.6%+1.8%+4.2%
All+9.8%+3.1%+6.7%+7.5%

Cumulative growth

Daily Returns

Daily percentage return beside EME.

Daily Out/Under-Performance

Portfolio return minus EME return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × EME return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 1y: compounded portfolio wealth divided by compounded EME wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

1y analysis · Full analysis span regression · 6 months rolling